Establishment of a Patient Library in Patients With Pruritus Sine Materia

Condition(s) studied

Investigational drug(s) / intervention(s)

Blood samples: At inclusion : * 52.5 ml of blood : * 24 ml plasma * 20 ml serum * 6 ml DNA * 2.5 ml RNA

skin swab sample: At inclusion a skin swab sample will be collected

skin biopsy sample: At inclusion a skin biopsy sample will be collected

Questionnaires: At inclusion, at 6 months and every year, the patient will respond to 5 questionnaires : Brest questionnaire, 5-D itch scale, Dermatology Life Quality Index, Itchy Quality of Life and Hospital Anxiety and Depression Scale

Study summary

Very little is currently known about the pathophysiology of pruritus sine materia according to the etiology. The creation of this cohort should make it possible to improve our clinical and biological knowledge according to the etiology, by collecting blood, skin, feces, and clinical data.

Eligibility

Primary outcome measure(s)

• Clinical description of the pruritus — 5 years
  Chronology
• Clinical description of the pruritus — 5 years
  Intensity
• Clinical description of the pruritus — 5 years
  Location
• Clinical description of the pruritus — 5 years
  Aggravating and ameliorating factors
• Clinical description of the pruritus — 5 years
  Evolution
• Clinical description of the pruritus — 5 years
  Scratching
• Clinical description of the pruritus — 5 years
  Chronology, intensity, location, aggravating and ameliorating factors, evolution, scratching
• 5-D itch scale questionnaire — 5 years
  The scores for each of the five domains (duration, degree, direction, disability, ditribution) are calculated separately and then added together to obtain a total 5-D score. The 5-D score can range from 5 (no pruritus) to 25 (most severe pruritus). Scores with a single item (duration, degree, direction) are equal to the value indicated by the answer choice (from 1 to 5). The impact of pruritus (disability) includes four items that assess the impact of itching on daily activities: sleep, leisure activities, social activities, domestic activities, work/study. The score for impact is reached by taking the highest score on any of the four items. For location (distribution), the number of body parts affected is collected (potential sum of 0 to 16) and the sum is classified into 5 scores: * sum of 0 to 2 = score of 1 * sum of 3 to 5 = score of 2 * sum of 6 to 10 = score of 3 * sum of 11 to 13 = score of 4 * sum of 14 to 16 = score of 5
• Dermatology Life Quality Index questionnaire (DLQI) — 5 years
  DLQI = Dermatology Life Quality Index is a ten-item questionnaire. The score ranges from 0 to 30. Each question is rated from 0 to 3. The higher the score, the worse the health status. Interpretation of DLQI: DLQI scores 0-1: no effect on patient's life DLQI scores 2-5: small effect on patient's life DLQI scores 6-10: moderate effect on patient's life DLQI scores 11-20: very large effect on patient's life DLQI scores 21-30: extremely large effect on patient's life
• Hospital anxiety and depression questionnaire (HAD) — 5 years
  The HAD scale is an instrument to screen for anxiety and depressive disorders. It consists of 14 items rated from 0 to 3. Seven questions relate to anxiety (total A) and seven others to the depressive dimension (total D), thus making it possible to obtain two scores (maximum score for each score = 21). To screen for anxiety and depressive symptoms, the following interpretation can be proposed for each of the scores (A and D) * 7 or less: no symptomatology * 8 to 10: doubtful symptomatology * 11 and more: definite symptomatology.
• Brest Questionnaire — 5 years
  The Brest questionnaire is a descriptive tool. No score is calculated.

Trial sites (1)

More University Hospital, Brest trials in France

Other trials for the same condition